Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire.
Robert P. Baughman(University of Cincinnati), Marc A. Judson(Cleveland Clinic), Joel Francesqui(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Marjon Elfferich(Ziekenhuis Gelderse Vallei), Paola Rottoli(University of Siena), Michelle Terwiel(St. Antonius Ziekenhuis), Tamara Al-Hakim(Pulmonary Fibrosis Foundation), Mindy Buchanan(Pulmonary Fibrosis Foundation), Marjolein Drent(Maastricht University), Nadera Sweiss(University of Illinois Chicago), Jacobo Sellarés(The Metabolomics Innovation Centre), Elyse E. Lower(University of Cincinnati), F Martone(Associazione Italiana Vulvodinia Onlus), María Rita Barriuso Cabrerizo(Madrid Institute for Advanced Studies)
Cited by 26
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
|American Journal of Transplantation|2011|1.6k
The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review
|Obesity Reviews|2006|1.4k
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Practice Guidelines for Diseases Caused by Aspergillus
|Clinical Infectious Diseases|2000|797